Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Accelerators
More organizations
Companies
Helmedix
Portfolio
Save
Helmedix
Developing novel therapies for autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and multiple sclerosis.
Overview
Similar companies
Investments (0)
Analytics
Notes
Job openings
Innovations (0)
All
Current
Exits
Rounds
Co-Investors
No columns specified